Literature DB >> 11394188

Unmasking social anxiety disorder.

M B Stein1, J M Gorman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11394188      PMCID： PMC1408304     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  56 in total

1.  Coming face-to-face with social phobia.

Authors:  M B Stein
Journal:  Am Fam Physician       Date:  1999-11-15       Impact factor: 3.292

Review 2.  Subtypes of social phobia and comorbidity with depression and other anxiety disorders.

Authors:  M B Stein; D A Chavira
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

3.  Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

Authors:  M A Van Ameringen ; R M Lane; J R Walker; R C Bowen; P R Chokka; E M Goldner; D G Johnston; Y J Lavallee; S Nandy; J C Pecknold; V Hadrava; R P Swinson
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

4.  Barriers to the treatment of social anxiety.

Authors:  M Olfson; M Guardino; E Struening; F R Schneier; F Hellman; D F Klein
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

Review 5.  Quality of life in individuals with anxiety disorders.

Authors:  M V Mendlowicz; M B Stein
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

6.  Parental psychopathology, parenting styles, and the risk of social phobia in offspring: a prospective-longitudinal community study.

Authors:  R Lieb; H U Wittchen; M Höfler; M Fuetsch; M B Stein; K R Merikangas
Journal:  Arch Gen Psychiatry       Date:  2000-09

7.  Disability and quality of life in social phobia: epidemiologic findings.

Authors:  M B Stein; Y M Kean
Journal:  Am J Psychiatry       Date:  2000-10       Impact factor: 18.112

Review 8.  Social phobia. Epidemiology and cost of illness.

Authors:  J D Lipsitz; F R Schneier
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

9.  Low dopamine D(2) receptor binding potential in social phobia.

Authors:  F R Schneier; M R Liebowitz; A Abi-Dargham; Y Zea-Ponce; S H Lin; M Laruelle
Journal:  Am J Psychiatry       Date:  2000-03       Impact factor: 18.112

10.  Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms.

Authors:  E C Nelson; J D Grant; K K Bucholz; A Glowinski; W Reich; A C Heath
Journal:  Psychol Med       Date:  2000-07       Impact factor: 7.723
View more
  7 in total

1.  The limits of psychiatry.

Authors:  Duncan Double
Journal:  BMJ       Date:  2002-04-13

Review 2.  Sex differences modulating serotonergic polymorphisms implicated in the mechanistic pathways of risk for depression and related disorders.

Authors:  LeeAnn M Perry; Andrea N Goldstein-Piekarski; Leanne M Williams
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 3.  Amygdala connectivity and implications for social cognition and disorders.

Authors:  Olivia C Meisner; Amrita Nair; Steve W C Chang
Journal:  Handb Clin Neurol       Date:  2022

4.  Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial.

Authors:  Murray B Stein; Mark H Pollack; Alexander Bystritsky; Jeffrey E Kelsey; Richard M Mangano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

5.  Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder.

Authors:  Murray B Stein; Soraya Seedat; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-03-09       Impact factor: 4.530

6.  Examining the Relationships Among Parental Overprotection, Military Life Adjustment, Social Anxiety, and Collective Efficacy.

Authors:  Kyounghee Bark; Jung Hee Ha; Juliet Jue
Journal:  Front Psychol       Date:  2021-02-11

Review 7.  Cerebral lateralization of pro- and anti-social tendencies.

Authors:  David Hecht
Journal:  Exp Neurobiol       Date:  2014-03-27       Impact factor: 3.261
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.